
### [NCIT:C3793](http://purl.obolibrary.org/obo/NCIT_C3793)
**Label:** Inverted Papilloma

**Subclasses:** [NCIT:C6192](http://purl.obolibrary.org/obo/NCIT_C6192) (Inverted Urothelial Papilloma), [NCIT:C4118](http://purl.obolibrary.org/obo/NCIT_C4118) (Inverted Transitional Cell Papilloma), [NCIT:C65165](http://purl.obolibrary.org/obo/NCIT_C65165) (Inverted Squamous Cell Papilloma), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), [NCIT:C35835](http://purl.obolibrary.org/obo/NCIT_C35835) (Salivary Gland Inverted Ductal Papilloma), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), 

**Class expressions from DL-Learner:**

- [NCIT:C47826](http://purl.obolibrary.org/obo/NCIT_C47826) (Diffuse Lesion) 53.85%
- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 53.85%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.85%
- Thing 52.89%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38698](http://purl.obolibrary.org/obo/NCIT_C38698) (Hyperviscosity))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38674](http://purl.obolibrary.org/obo/NCIT_C38674) (Widespread Disease))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38667](http://purl.obolibrary.org/obo/NCIT_C38667) (Polymorphic Cellular Infiltrate))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38666](http://purl.obolibrary.org/obo/NCIT_C38666) (Monomorphic Cellular Infiltrate))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38665](http://purl.obolibrary.org/obo/NCIT_C38665) (Chest Pain))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38661](http://purl.obolibrary.org/obo/NCIT_C38661) (Composite Lymphoma))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38660](http://purl.obolibrary.org/obo/NCIT_C38660) (Neoplastic Large B-Lymphocyte with Pale Cytoplasm))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C3866](http://purl.obolibrary.org/obo/NCIT_C3866) (Esophageal Leiomyoma))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38658](http://purl.obolibrary.org/obo/NCIT_C38658) (Transformed Peripheral B-Lymphocyte))) 39.20%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38657](http://purl.obolibrary.org/obo/NCIT_C38657) (Neoplastic Immunoblast-Like B-Lymphocyte))) 39.20%


